PROVIREX enables the future production of CAR-T cells

First cleanroom for CAR-T cell production in Hamburg - also for people with HIV when indicated

The CAR-T cell therapy has been expanding treatment options in Germany since 2018 for people with certain hematologic-oncological diseases. Cells for the personalized therapy are currently mostly produced in U.S. laboratories. This requires complex logistics and is associated with high costs. The bi…

A look at the NEWSLETTER

Better informed: With YEARBOOK, NEWSLETTER, NEWSFLASH, NEWSEXTRA and EXPERT DIRECTORY

Stay up to date and subscribe to our monthly eMail-NEWSLETTER and our NEWSFLASH and NEWSEXTRA. Get additional information about what is happening in the world of cleanrooms with our printed YEARBOOK. And find out who the cleanroom EXPERTS are with our directory.